ICL

ICL Group Ltd

Add to Watchlist

Advanced Chart

6.190

-0.01(-0.161%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

6.240

Open

6.240

VWAP

6.17

Vol

921.43K

Mkt Cap

7.99B

Low

6.135

Amount

5.69M

EV/EBITDA(TTM)

Total Shares

1.29B

10.35B

EV/OCF(TTM)

8.36

P/S(TTM)

ICL Group Ltd, formerly known as Israel Chemicals Ltd, is an Israel-based company, which is engaged in the fertilizer and specialty chemical sectors. The Company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from different sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus, elemental bromine, and other chemicals. The Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

0.00

-100%

0.105

-4.55%

0.101

+26.25%

0.111

+23.33%

Estimates Revision

The market is revising Downward the revenue expectations for ICL Group Ltd (ICL) for FY2025, with the revenue forecasts being adjusted by -1.43% over the past three months. During the same period, the stock price has changed by -10.42%.

Revenue Estimates for FY2025

Revise Downward

-1.43%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-5.96%

In Past 3 Month

Stock Price

Go Down

-10.42%

In Past 3 Month

3 Analyst Rating

7.43% Upside

Wall Street analysts forecast ICL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICL is 6.65 USD with a low forecast of 6.20 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

3 Hold

0 Sell

Hold

7.43% Upside

Current: 6.190

Low

6.20

Averages

6.65

High

7.00

7.43% Upside

Current: 6.190

Low

6.20

Averages

6.65

High

7.00

Morgan Stanley

Vincent Andrews

Equal Weight

maintain

2025-07-02

Reason

Morgan Stanley

Vincent Andrews

Price Target

2025-07-02

maintain

Equal Weight

Reason

Morgan Stanley analyst Vincent Andrews raised the firm's price target on ICL to $6.20 from $5.80 and keeps an Equal Weight rating on the shares.

Barclays

Benjamin Theurer

Hold

Maintains

$6 → $7

2025-03-05

Reason

Barclays

Benjamin Theurer

Price Target

$6 → $7

2025-03-05

Maintains

Hold

Reason

Barclays raised the firm's price target on ICL to $7 from $6 and keeps an Equal Weight rating on the shares. After a volatile start to crop prices and agriculture input pricing, March started with a tariff dispute and increased uncertainty for U.S. farmers, the analyst tells investors in a research note. The firm remains cautious on the broader fertilizer group.

BMO Capital

Joel Jackson

Hold

Maintains

$6 → $6.5

2025-02-27

Reason

BMO Capital

Joel Jackson

Price Target

$6 → $6.5

2025-02-27

Maintains

Hold

Reason

Barclays

Benjamin Theurer

Sell

Hold

Upgrades

$4 → $6

2025-01-21

Reason

Barclays

Benjamin Theurer

Price Target

$4 → $6

2025-01-21

Upgrades

Sell

Hold

Reason

Barclays upgraded ICL to Equal Weight from Underweight with a price target of $6, up from $4. Entering 2025, the firm is more optimistic about crop protection and maintains a positive outlook on diversified international protein names and ingredients. In contrast, Barclays adds caution to its grain processor coverage and adjusted ratings in fertilizer given the recent run-up in share prices. It recognizes the strength in potash volumes in 2024 did not bring stock appreciation for the major potash players.

Barclays

Benjamin Theurer

Sell

Maintains

$4.5 → $4

2024-08-16

Reason

Barclays

Benjamin Theurer

Price Target

$4.5 → $4

2024-08-16

Maintains

Sell

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for ICL Group Ltd (ICL.N) is 14.00, compared to its 5-year average forward P/E of 11.03. For a more detailed relative valuation and DCF analysis to assess ICL Group Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

11.03

Current PE

14.00

Overvalued PE

14.06

Undervalued PE

8.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

6.11

Current EV/EBITDA

6.45

Overvalued EV/EBITDA

7.30

Undervalued EV/EBITDA

4.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.12

Current PS

1.04

Overvalued PS

1.35

Undervalued PS

0.89